|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.45M 4.57M 4.32M 3.92M 7.36M 499M 7.4M 51.74M 19.98M 255M 19.51M 19.09M 818M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.19M 8.69M 7.88M 14.8M 1B 14.88M 104M 40.17M 512M 39.22M 38.37M 1.64B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,056B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 655B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 471B | |
| -0.42% | -2.58% | +40.20% | +42.33% | 342B | |
| +0.28% | +4.53% | +23.37% | +29.55% | 277B | |
| +1.47% | -0.54% | +13.56% | +13.50% | 257B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 226B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 189B | |
| +0.65% | -2.98% | -27.62% | -61.28% | 170B | |
| Average | +0.45% | +0.97% | +30.45% | +49.57% | 364.29B | |
| Weighted average by Cap. | +0.16% | +1.04% | +40.70% | +69.94% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 103M 7.82M 7.4M 6.71M 12.6M 854M 12.67M 88.55M 34.2M 436M 33.39M 32.66M 1.4B | 9.91M 115M 8.72M 8.24M 7.48M 14.04M 951M 14.12M 98.68M 38.11M 485M 37.2M 36.4M 1.56B |
| Net income | 665K 7.74M 585K 553K 502K 942K 63.84M 948K 6.62M 2.56M 32.57M 2.5M 2.44M 105M | 762K 8.86M 670K 633K 574K 1.08M 73.1M 1.09M 7.58M 2.93M 37.3M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.24M 3.65M 3.45M 3.13M 5.87M 398M 5.91M 41.3M 15.95M 203M 15.57M 15.23M 653M | 5.25M 61.07M 4.62M 4.37M 3.96M 7.44M 504M 7.48M 52.28M 20.19M 257M 19.71M 19.28M 826M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
